CeriBell, Inc Market Cap ($888.45 Million)
Market Cap & Net Worth: CeriBell, Inc (CBLL)
CeriBell, Inc market cap. CeriBell, Inc (NASDAQ:CBLL) has a market capitalization of $888.45 Million ($888.45 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9051 globally and #2576 in its home market, demonstrating a 4.59% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CeriBell, Inc's stock price $28.27 by its total outstanding shares 38378101 (38.38 Million). Also see CeriBell, Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
CeriBell, Inc Market Cap History (2024–2026)
CeriBell, Inc market cap history from 2024 to 2026. Data shows growth from $993.23 Million to $1.08 Billion (27.92% CAGR). Check CBLL stock price and chart for real-time trading data and today's change.
Index Memberships
CeriBell, Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.03% | #258 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #967 of 3165 |
Weight: CeriBell, Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CeriBell, Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CeriBell, Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of CeriBell, Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
9.45x
CeriBell, Inc's market cap is 9.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $993.23 Million | $65.44 Million | -$40.45 Million | 15.18x | N/A |
| 2025 | $841.63 Million | $89.06 Million | -$53.41 Million | 9.45x | N/A |
Competitor Companies of CBLL by Market Capitalization
Companies near CeriBell, Inc in the global market cap rankings as of November 5, 2026. Also see CeriBell, Inc asset portfolio for a full breakdown of the balance sheet.
Key companies related to CeriBell, Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of CeriBell, Inc (2024–2026)
Market capitalization of CeriBell, Inc from 2024 to today. Between 2024 and today, CeriBell, Inc's market cap moved from $993.23 Million to $ 1.08 Billion, with a yearly change of 27.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.08 Billion | +28.91% |
| 2025 | $841.63 Million | -15.26% |
| 2024 | $993.23 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of CeriBell, Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $888.45 Million USD |
| MoneyControl | $888.45 Million USD |
| MarketWatch | $888.45 Million USD |
| marketcap.company | $888.45 Million USD |
| Reuters | $888.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more